Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marit Rasmussen

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cellular Oncology (Dordrecht, Netherlands)|December 23, 2025
PARP7 and aryl hydrocarbon receptor differentially regulate mammary cancer cell proliferation and STING-induced type I interferon signallingNinni E Olafsen, Samaneh S Åhrling, Marit Rasmussen, et al.
Cancers|July 29, 2023
Loss of PARP7 Increases Type I Interferon Signaling in EO771 Breast Cancer Cells and Prevents Mammary Tumor Growth by Increasing Antitumor ImmunityMarit Rasmussen, Karoline Alvik, Vinicius Kannen, et al.
Cells|April 3, 2021
PARP7 and Mono-ADP-Ribosylation Negatively Regulate Estrogen Receptor α Signaling in Human Breast Cancer CellsMarit Rasmussen, Susanna Tan, Venkata S Somisetty, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 15, 2021
2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD)-Inducible Poly-ADP-Ribose Polymerase (TIPARP/PARP7) Catalytic Mutant Mice (TiparpH532A) Exhibit Increased Sensitivity to TCDD-Induced Hepatotoxicity and LethalityDavid Hutin, Alexandra S Long, Kim Sugamori, et al.
Elife|January 21, 2021
Chemical genetics and proteome-wide site mapping reveal cysteine MARylation by PARP-7 on immune-relevant protein targetsKelsie M Rodriguez, Sara C Buch-Larsen, Ilsa T Kirby, et al.
Frontiers in Immunology|January 27, 2025
Loss of <i>Parp7</i> increases type I interferon signalling and reduces pancreatic tumour growth by enhancing immune cell infiltrationVinicius Kannen, Marit Rasmussen, Siddhartha Das, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cellular Oncology (Dordrecht, Netherlands)|December 23, 2025
PARP7 and aryl hydrocarbon receptor differentially regulate mammary cancer cell proliferation and STING-induced type I interferon signallingNinni E Olafsen, Samaneh S Åhrling, Marit Rasmussen, et al.
Cancers|July 29, 2023
Loss of PARP7 Increases Type I Interferon Signaling in EO771 Breast Cancer Cells and Prevents Mammary Tumor Growth by Increasing Antitumor ImmunityMarit Rasmussen, Karoline Alvik, Vinicius Kannen, et al.
Cells|April 3, 2021
PARP7 and Mono-ADP-Ribosylation Negatively Regulate Estrogen Receptor α Signaling in Human Breast Cancer CellsMarit Rasmussen, Susanna Tan, Venkata S Somisetty, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 15, 2021
2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD)-Inducible Poly-ADP-Ribose Polymerase (TIPARP/PARP7) Catalytic Mutant Mice (TiparpH532A) Exhibit Increased Sensitivity to TCDD-Induced Hepatotoxicity and LethalityDavid Hutin, Alexandra S Long, Kim Sugamori, et al.
Elife|January 21, 2021
Chemical genetics and proteome-wide site mapping reveal cysteine MARylation by PARP-7 on immune-relevant protein targetsKelsie M Rodriguez, Sara C Buch-Larsen, Ilsa T Kirby, et al.
Frontiers in Immunology|January 27, 2025
Loss of <i>Parp7</i> increases type I interferon signalling and reduces pancreatic tumour growth by enhancing immune cell infiltrationVinicius Kannen, Marit Rasmussen, Siddhartha Das, et al.
Pageof 1